[go: up one dir, main page]

TWI387460B - Extraction methods and compositions to ameliorate hyperlipidemia, hyperglycermia and fatty liver - Google Patents

Extraction methods and compositions to ameliorate hyperlipidemia, hyperglycermia and fatty liver Download PDF

Info

Publication number
TWI387460B
TWI387460B TW98121165A TW98121165A TWI387460B TW I387460 B TWI387460 B TW I387460B TW 98121165 A TW98121165 A TW 98121165A TW 98121165 A TW98121165 A TW 98121165A TW I387460 B TWI387460 B TW I387460B
Authority
TW
Taiwan
Prior art keywords
powder
hours
fatty liver
residue
bitter gourd
Prior art date
Application number
TW98121165A
Other languages
Chinese (zh)
Other versions
TW201100088A (en
Inventor
Tsung Chi Tsai
Hsien Tung Yen
Chia Chun Lin
Ih Jen Su
Original Assignee
Uni President Entpr Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni President Entpr Corp filed Critical Uni President Entpr Corp
Priority to TW98121165A priority Critical patent/TWI387460B/en
Publication of TW201100088A publication Critical patent/TW201100088A/en
Application granted granted Critical
Publication of TWI387460B publication Critical patent/TWI387460B/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Description

一種具有調降血糖血脂以及脂肪肝的多效複方食品組合及其各素材之抽出方法Multi-effect compound food combination with blood sugar lowering blood fat and fatty liver and extraction method of each material thereof

一種保健食品之配方組合及其各素材之抽出方法Formulation combination of health food and extraction method of each material thereof

在已開發國家中,脂質與醣類代謝不佳,容易產生代謝症候群的症狀,如糖尿病、高血壓、高血脂、動脈硬化、高三酸甘油酯等疾病,然近年來的研究發現,這些疾病都與細胞核中的受體-PPARs(脂小體活化增生受體)有關。目前有許多科學家都在找尋可以活化PPARs的活化子當成代謝症候群的藥物,例如:thiazolidinediones(TZD)(胰島素增敏劑)為活化PPARγ而具有降血糖的效果,而fibrates(苯氧芳雙類)為活化PPARα且有降血脂的效果,但由於以上皆屬於藥物,同時具有副作用,不適合長期食用。In developed countries, lipids and carbohydrates are poorly metabolized, and they are prone to symptoms of metabolic syndrome, such as diabetes, hypertension, hyperlipidemia, arteriosclerosis, and high triglycerides. However, recent studies have found that these diseases are It is associated with receptor-PPARs (liposome-activated proliferating receptors) in the nucleus. Many scientists are currently looking for drugs that activate PPARs as metabolic syndromes. For example, thiazolidinediones (TZD) (insulin sensitizer) has the effect of lowering blood glucose by activating PPARγ, while fibrates (phenoxy aryl) In order to activate PPARα and have the effect of lowering blood fat, but because all of the above are drugs, and have side effects, it is not suitable for long-term consumption.

近年來,有少量文獻由一些古方常用的降血糖素材,驗證是否是經由活化PPARγ而達到降血糖的效果,並期望可以由這些天然的成分去找尋更強可以活化PPAR的化合物,以便進行藥物的開發。目前文獻的素材都是以單方為主,例如:啤酒花抽出物可以同時活化PPARα及γ、苦瓜抽出物可以同時活化PPARα及γ、甘草抽出物活化PPARγ...等,但這些有效成分往往需要經過特殊的有機溶劑去萃取,才可以獲得有效的成分。但以食品的觀念,經過有機溶劑萃取並不適合應用於食品。所以本專利就是利用特殊酒精和/或水的抽取及配合最佳之各素材之組合比例,以獲得最有效(血脂、血糖、脂肪肝)的食品複方配方。In recent years, a small amount of literature has been used to reduce blood glucose by activating PPARγ, and it is expected that these natural ingredients can be used to find stronger compounds that can activate PPAR for drug use. Development. At present, the materials in the literature are mainly unilateral. For example, hop extracts can simultaneously activate PPARα and γ, bitter melon extract can simultaneously activate PPARα and γ, licorice extract activates PPARγ, etc., but these active ingredients often need to pass through. Special organic solvents are extracted to obtain effective ingredients. However, in the concept of food, organic solvent extraction is not suitable for food. Therefore, this patent is to use the combination of special alcohol and / or water and the best combination of materials to obtain the most effective food formula for blood lipids, blood sugar, fatty liver.

目前降血糖及降血脂的藥物有許多都是經由活化PPAR α及γ所開發完成,所以功效及機制原理已經經過許多專家學者確認,但是這一類的藥品,往往因為化學合成的化合物,而使一些受試者產生肝臟或腎臟的毒性,因而使身體的GOT(麩氨基酸草醋酸轉氨基酵素)及GPT(麩氨基酸焦葡萄轉氨基酵素)值變高,所以本專利的想法就是利用醫藥界找尋活化活化物的方法,對於目前人類常吃的素材以食品可用的溶劑進行篩選,找出具有活化PPAR α及γ天然化合物或複方組合,以造福更多的人。Many of the drugs for lowering blood sugar and lowering blood fat have been developed through the activation of PPAR α and γ. Therefore, the principle of efficacy and mechanism has been confirmed by many experts and scholars, but this type of medicine is often caused by chemically synthesized compounds. The subject produces liver or kidney toxicity, which makes the body's GOT (breast amino acid acetic acid transaminase) and GPT (brome amino acid pyroglucan amino acid) values higher, so the idea of this patent is to use the medical community to find activation. The method of activating substances is to screen the materials which are commonly eaten by humans in foods, and to find out those having activated PPAR α and γ natural compounds or compound combinations for the benefit of more people.

本創意是一種具有調降血糖血脂以及改善脂肪肝的多效複方食品組合及其抽取方法,其特徵在於添加比例為苦瓜20~40%、甘草1%~10%、綠藻15%~30%、大豆蛋白粉20~40%。而其各素材抽出物之抽取方法分別如下:The present invention is a multi-effect compound food combination and a method for extracting the same, which are characterized in that the ratio of addition is 20~40% of bitter gourd, 1%~10% of licorice, 15%~30% of green algae. Soy protein powder 20~40%. The extraction methods of each material extraction are as follows:

甲、苦瓜抽出物:100克新鮮苦瓜先以榨汁機榨取苦瓜汁液,剩餘的殘渣再以100~200 ml 90%以上的酒精浸泡6至8個小時後,過濾去除殘渣,把苦瓜汁液和酒精抽提物混合進行冷凍乾燥,製成粉末而成。A, bitter gourd extract: 100 grams of fresh bitter gourd juice extracts bitter gourd juice, the remaining residue is then soaked in 100 ~ 200 ml 90% alcohol for 6 to 8 hours, filtered to remove residue, bitter gourd juice and alcohol The extract is mixed and freeze-dried to form a powder.

乙、甘草抽出物:100克甘草經過粉碎後,加入500~1000ml體積的純水以60~100rpm振盪室溫浸泡10小時以上,除去甘草殘渣後,將上清液冷凍乾燥成粉末,此一粉末再以50~100ml甲醇浸泡20小時以上,將醇溶的部份再乾燥成粉末而成。B, licorice extract: 100 grams of licorice after pulverization, add 500 ~ 1000ml volume of pure water at 60 ~ 100rpm shaking room temperature for more than 10 hours, remove the licorice residue, the supernatant is freeze-dried into a powder, this powder The mixture is further immersed in 50-100 ml of methanol for more than 20 hours, and the alcohol-soluble portion is further dried into a powder.

丙、破壁綠藻:100克破壁綠藻粉,以500~1000 ml 100℃沸水進行抽取60~180分鐘,將此水溶液以10mm-5 mm以分子篩過濾,除去殘渣部份,水溶液部分進行濃縮與乾燥噴粉而成。C, broken wall green algae: 100 grams of broken green algae powder, 500 ~ 1000 ml 100 ° C boiling water for 60 ~ 180 minutes, the aqueous solution is filtered with 10ml - 5 mm molecular sieve, remove the residue part, the aqueous solution part Concentrated and dried powdered.

丁、大豆蛋白粉:100克脫油的豆粕,以300~500ml的水,加入0.3%~3%蛋白分解酵素endopeptidase(E.C.3.4.24.28),於45-50度下作用6-8小時,經過過濾,取濾液,以分子篩過濾取10000 Dalton以下的成分。Ding, soy protein powder: 100 grams of deoiled soybean meal, with 300~500ml of water, adding 0.3%~3% proteolytic enzyme endopeptidase (EC3.4.24.28), acting at 45-50 degrees for 6-8 hours, after Filtration, taking the filtrate, and filtering with a molecular sieve to obtain a component of 10,000 Dalton or less.

將上述的配方組成進行動物與人體試驗的使用,證實有調降血脂、血糖與改善脂肪肝的功效,且以上製程的複方組合效果好具有好的水中擴散性,可以應用其他複方食品組合,包括膠囊錠劑、穀粉、飲料、口服液產品的開發。The above formula is used for animal and human test, which proves that it has the effects of lowering blood fat, blood sugar and improving fatty liver, and the combination of the above processes has good water diffusion property, and other compound food combinations can be applied, including Development of capsule lozenges, cereal flour, beverages, and oral liquid products.

利用所建立轉染PPAR α及PPAR γ之細胞的方法(transactivation assay system)(轉染細胞活化系統)---於活化PPAR啟動子基因的後方,接入冷光的基因,再把此基因送入表現的肝臟細胞,接著使用素材去刺激細胞,當素材具有活化PPAR的能力,即可以由冷光儀測出冷光的強弱變化,以此決定素材活化PPAR α及PPAR γ的效果,也可以應用此技術決定製程及搭配複方組合。Using the transactivation assay system (transfected cell activation system) that has been established to transfect PPAR alpha and PPAR gamma - to activate the PPAR promoter gene, access the luminescent gene, and then send the gene into The liver cells are expressed, and then the material is used to stimulate the cells. When the material has the ability to activate PPAR, the intensity of cold light can be measured by a luminometer to determine the effect of the material on the activation of PPAR α and PPAR γ. Decide on the process and match the combination.

經過對許多食品素材進行篩選,發現以下四個素材有很好的活性,並進行不同萃取方式,找出以下的專利製程,有最好的活化PPAR效果,製造的方法如下:After screening a lot of food materials, the following four materials were found to be very active, and different extraction methods were carried out to find out the following patented processes, which have the best activated PPAR effect. The manufacturing methods are as follows:

甲、苦瓜抽出物:100克新鮮苦瓜先以榨汁機榨取苦瓜汁液,餘殘的渣再以100~200 ml 90%以上的酒精浸泡6至8個小時後,過濾去除殘渣,把苦瓜汁液和酒精抽提物混合進行冷凍乾燥,製成粉末而成。A, bitter gourd extract: 100 grams of fresh bitter gourd first extract the bitter gourd juice with a juicer, and the remaining residue is soaked in 100~200 ml 90% alcohol for 6-8 hours, filtered to remove the residue, and the bitter gourd juice and The alcohol extract is mixed and freeze-dried to form a powder.

乙、甘草抽出物:100克甘草經過粉碎後,加入500~1000ml體積的純水以60~100rpm振盪室溫浸泡10小時以上,除去甘草殘渣後將上清液冷凍乾燥成粉末,此一粉末再以50~100ml甲醇浸泡20小時以上,將醇溶的部份再乾燥成粉末而成。B, licorice extract: 100 grams of licorice after pulverization, add 500 ~ 1000ml volume of pure water at 60 ~ 100rpm shaking room temperature for more than 10 hours, remove the licorice residue, the supernatant is freeze-dried into a powder, this powder and then Soak in 50-100 ml of methanol for more than 20 hours, and then dry the alcohol-soluble portion into a powder.

丙、破壁綠藻:100克破壁綠藻粉,以500~1000 ml 100℃沸水進行抽取60~180分鐘,將此水溶液以10mm-5 mm以分子篩過濾,除去殘渣部份,水溶液部分進行濃縮與乾燥噴粉而成。C, broken wall green algae: 100 grams of broken green algae powder, 500 ~ 1000 ml 100 ° C boiling water for 60 ~ 180 minutes, the aqueous solution is filtered with 10ml - 5 mm molecular sieve, remove the residue part, the aqueous solution part Concentrated and dried powdered.

丁、大豆蛋白粉:100克脫油的豆粕,以300~500ml的水,加入0.3%~3%蛋白分解酵素endopeptidase(E.C.3.4.24.28),於45-50度下作用6-8小時,經過過濾,取濾液,以分子篩過濾取10000 Dalton以下的成分。Ding, soy protein powder: 100 grams of deoiled soybean meal, with 300~500ml of water, adding 0.3%~3% proteolytic enzyme endopeptidase (EC3.4.24.28), acting at 45-50 degrees for 6-8 hours, after Filtration, taking the filtrate, and filtering with a molecular sieve to obtain a component of 10,000 Dalton or less.

接著進行複方的組合及搭配,利用以上四個專利製程所抽取的素材,找出最佳的誘發劑量的活性,此外也進行素材排列組合,實驗結果發現這四種素材搭配在一起後,經過PPAR α及PPAR γ之細胞株篩選方法確定效果比單方或是其他配方任意組合(總濃度相同下比較)有更好的活化PPAR α及PPAR γ的能力(如下圖一及圖二)。圖一:表示活化PPAR α的倍數,圖二表示活化PPAR γ的倍數。而控制組為只用水去刺激細胞的結果,定其活化倍數為100%(1倍),而甘草、苦瓜、綠藻、大豆其對PPARα的最高活化程度只有1.5、1.4、2.3、2.1倍,當四個成份組合一起時,PPARα的最高活化程度可以高達5.3倍,而四個單方對PPARγ的最高活化程度分別為2.9、1.3、1.8、1.9倍,當四個成份組合一起時,對PPARγ的最高活化程度高達5.0倍,以上結果証實此複方組合具有可加成活化PPARα和γ的效果,優於單方的組合,有其進步性。Then carry out the combination and matching of the compound, and use the materials extracted by the above four patent processes to find the best dose-inducing activity. In addition, the material arrangement and combination are also carried out. The experimental results show that the four materials are matched together and pass the PPAR. The screening method for α and PPAR γ cell lines has better ability to activate PPAR α and PPAR γ than any combination of unilateral or other formulations (compared to the same total concentration) (see Figure 1 and Figure 2 below). Figure 1: shows the multiple of activated PPAR α, and Figure 2 shows the multiple of activated PPAR γ. The control group was the result of only stimulating the cells with water, and the activation factor was 100% (1 time), while the highest activation degree of PPARα was only 1.5, 1.4, 2.3, 2.1 times for licorice, bitter gourd, green algae and soybean. When the four components are combined, the highest activation degree of PPARα can be as high as 5.3 times, and the maximum activation degree of four unilateral PPARγ is 2.9, 1.3, 1.8, 1.9 times, respectively. When the four components are combined, the PPARγ is combined. The highest activation degree is up to 5.0 times. The above results confirm that the compound combination has the effect of adding PPARα and γ, which is superior to the single combination and has progress.

將上述的配方組合進一步進行血脂、血糖與脂肪肝的體內試驗,以進一步證實其功效The above formula combination is further tested in vivo for blood lipids, blood sugar and fatty liver to further confirm its efficacy

■血脂血糖動物實驗: 以成大動物中心所購買的C57BL/6品系老鼠,經過高脂肪飼料的誘發,使老鼠產生高血糖及高血脂的症狀,經過我們設計的配方餵食老鼠,可以發現老鼠經過3個星期餵食後,具有降血糖(14.6%)及三酸甘油酯(21.8%)的效果,而在第六個星期可以看到降膽固醇(12.4%)的效果。 ■ Blood Lipid Blood Sugar Animal Experiment: C57BL/6 strain mice purchased from Chengda Animal Center, induced by high-fat diet, cause hyperglycemia and hyperlipidemia in mice. After we designed the mice, we can find the mice. After 3 weeks of feeding, it had the effect of lowering blood sugar (14.6%) and triglyceride (21.8%), and in the sixth week, the effect of lowering cholesterol (12.4%) was observed.

■血脂血糖人體體驗: 在血糖體驗者部份,經過一個月的服用,血糖平均值由99.1 mg/dl降至94.3mg/dl(降幅5%)。而在血脂體驗者的部分,經過一個月的測試,所有體驗者的膽固醇平均值由233 mg/dl降至207 mg/dl(降幅11.1%);而三酸甘油酯的平均值由221mg/dl降至162mg/dl(降幅26.7%),體驗者有高達100%的滿意效果。體驗期間體驗者的肝臟指數(麩氨基酸草醋酸轉氨基酵素及麩氨基酸焦葡萄轉氨基酵素)及腎臟指數(肌酸酐),都沒有上升,甚至還下降,證實專利配方安全不會造成肝、腎的負擔。當體驗者不繼續服用專利配方(超過一個月),就可以看到體驗者的血糖及血脂(除了三酸甘油酯)都有回升現象,證實所降的血糖、血脂為專利配方的效果。 ■ Blood lipids Blood sugar human experience: In the blood sugar experience part, after one month of taking, the average blood glucose level decreased from 99.1 mg/dl to 94.3 mg/dl (a decrease of 5%). In the blood lipid experience part, after one month of testing, the average cholesterol value of all experiencers decreased from 233 mg/dl to 207 mg/dl (a decrease of 11.1%); while the average value of triglycerides was 221 mg/dl. Dropped to 162mg/dl (down 26.7%), the experience has a 100% satisfaction. During the experience period, the experiencer's liver index (breast amino acid acetic acid transaminase and bran amino acid pyrogal aminotransferase) and kidney index (creatinine) did not rise or even decreased, confirming that the patented formula would not cause liver and kidney. The burden. When the experiencer does not continue to take the patented formula (more than one month), it can be seen that the blood sugar and blood lipids (except triglycerides) of the experiencer have rebounded, confirming that the lowered blood sugar and blood lipids are the effects of the patented formula.

脂肪肝動物實驗: 以成大動物中心所購買的C57BL/6品系老鼠,經過高脂肪及高果糖飼料誘發,並於飲水中加入酒精,使老鼠產生脂肪肝的症狀,經過我們設計的配方餵食老鼠,可以發現老鼠經過2個月餵食後,可以調降肝指數(麩氨基酸焦葡萄轉氨基酵素),有服用專利配方老鼠的麩氨基酸焦葡萄轉氨基酵素指數由50U/L降到36U/L,沒有服用專利配方控制組的麩氨基酸焦葡萄轉氨基酵素指數由51U/L上升到55U/L。另外也犧牲老鼠,由老鼠的肝臟可以發現,有服用配方老鼠的肝臟三酸甘油酯含量平均為23mg,沒有服用配方的控制組平均為28mg,且有顯著差異,而老鼠腹部以及皮下的脂肪,服用專利配方明顯比沒有服用的低,因此此專利配方具有減少脂肪堆積之效。Fatty liver animal experiment: C57BL/6 strain mice purchased by Chengda Animal Center were induced by high fat and high fructose feed, and alcohol was added to the drinking water to make the rats develop symptoms of fatty liver. In mice, it can be found that after 2 months of feeding, the rats can reduce the liver index (brome amino acid pyramid aminotransferase), and the transglutaminase amino acid enzyme index of the patented formula mouse is reduced from 50 U/L to 36 U/L. The transaminase index of the bran amino acid coke grape without the patented formula control group increased from 51 U/L to 55 U/L. In addition, the rats were sacrificed. The liver of the mice was found to have an average of 23 mg of liver triglyceride in the formula-treated mice and 28 mg in the control group without the formula, and there was a significant difference in the abdominal and subcutaneous fat of the mice. The patented formula is significantly lower than that not taken, so this patented formula has the effect of reducing fat accumulation.

脂肪肝人體實驗: 此專利配方進行人體體驗,三個月後,可以看到平均生化值有調降的效果,包括麩氨基酸草醋酸轉氨基酵素(由46U/L調降到30U/L),麩氨基酸焦葡萄轉氨基酵素(由45U/L調降到35U/L),三酸甘油酯(由204mg/dl調降到169mg/dl),總膽固醇(由220mg/dl調降到200mg/dl)都有明顯的改善,甚至有多位體驗者可以在3個月內,由超音波判斷的中度脂肪肝改善成為輕度或輕中度脂肪肝。Fatty liver human experiment: This patented formula for human experience, after three months, you can see the effect of the reduction of the average biochemical value, including bran amino acid grass acetic acid transaminase (from 46U / L down to 30U / L) , Bran amino acid Jiao grape transaminase (from 45U / L down to 35U / L), triglyceride (from 204mg / dl down to 169mg / dl), total cholesterol (from 220mg / dl down to 200mg / Dl) has obvious improvement, even a number of experiencers can improve the moderate fatty liver judged by ultrasound to mild or mild to moderate fatty liver within 3 months.

目前此專利配方不同於市面上只作用於腸胃道,抑制油脂吸收的產品,且市面上也沒有同時訴求降血糖及降血脂以及改善脂肪肝多效的產品,所以這個專利配方及其各素材之抽出法,是具有新穎性及進步性、產業利用之專利要件。At present, this patented formula is different from the products that only act on the gastrointestinal tract and inhibit the absorption of oil, and there is no product in the market that simultaneously appeals to lowering blood sugar and lowering blood fat and improving fatty liver. Therefore, this patent formula and its materials are The extraction method is a patent element with novelty and progressiveness and industrial utilization.

Claims (5)

一種具有調降血脂以及改善脂肪肝的多效複方食品組合物,其特徵在於該多效複方食品組合物是依下列方法抽取而得;(1)苦瓜抽出物:100克新鮮苦瓜先以榨汁機榨取苦瓜汁液,餘殘的渣再以100~200 ml 90%以上的酒精浸泡6至8個小時後,過濾去除殘渣,把苦瓜汁液和酒精抽提物混合進行冷凍乾燥,製成粉末而成;(2)甘草抽出物:100克甘草經過粉碎後,加入500~1000ml體積的純水以60~100rpm振盪室溫浸泡10小時以上,除去甘草殘渣後將上清液冷凍乾燥成粉末,此一粉末再以50~100ml甲醇浸泡20小時以上,將醇溶的部份再乾燥成粉末而成;(3)破壁綠藻:100克破壁綠藻粉,以500~1000 ml 100℃沸水進行抽取60~180分鐘,將此水溶液以10mm-5 mm以分子篩過濾,除去殘渣部份,水溶液部分進行濃縮與乾燥噴粉而成;(4)大豆蛋白粉:100克脫油的豆粕,以300~500ml的水,加入0.3%~3%蛋白分解酵素endopeptidase(E.C.3.4.24.28),於45-50度下作用6-8小時,經過過濾,取濾液,以分子篩過濾取10000 Dalton以下的成分。 A multi-effect compound food composition having blood fat lowering and improved fatty liver, characterized in that the multi-effect compound food composition is obtained by the following method; (1) bitter gourd extract: 100 g fresh bitter gourd first juiced The bitter gourd juice is extracted by the machine, and the remaining residue is soaked in 100~200 ml of 90% or more alcohol for 6 to 8 hours, and then the residue is removed by filtration, and the bitter gourd juice and the alcohol extract are mixed and freeze-dried to obtain a powder. (2) Licorice extract: After crushing 100 g of licorice, add 500-1000 ml of pure water and soak for 60 hours at 60-100 rpm for 10 hours or more. After removing the licorice residue, the supernatant is freeze-dried into a powder. The powder is further immersed in 50-100 ml of methanol for more than 20 hours, and the alcohol-soluble portion is further dried into a powder; (3) Broken green algae: 100 g of broken green algae powder, with 500-1000 ml of 100 ° C boiling water After taking 60~180 minutes, the aqueous solution is filtered by molecular sieve at 10mm-5mm to remove the residue, and the aqueous solution is partially concentrated and dried to be sprayed; (4) Soy protein powder: 100g of deoiled soybean meal, 300 ~500ml of water, adding 0.3% to 3% protein decomposition Su endopeptidase (E.C.3.4.24.28), under the action of 45-50 for 6-8 hours, filtered, the filtrate, was collected by filtration to 10000 Dalton molecular sieve following components. 依申請專利範圍第1項所述之一種具有調降血脂以及改善脂肪肝的多效複方食品組合物,可同時活化PPAR α(降血脂)與PPAR γ(降血糖),並具有改善脂肪肝的功效。 A multi-effect combination food composition having blood fat lowering and improved fatty liver according to claim 1 of the patent application can simultaneously activate PPAR α (hypolipidemic) and PPAR γ (hypoglycemia), and has an improved fatty liver. efficacy. 依申請專利範圍第1項所述之一種具有調降血脂以及改善脂肪肝的多效複方食品組合物,其產品型態包括:膠囊、錠劑、粉類與口服液四種型態。 A multi-effect combination food composition having a blood lipid lowering and improved fatty liver according to the first aspect of the patent application, the product type comprising: capsules, tablets, powders and oral liquids. 一種具有調降血脂以及改善脂肪肝的多效複方食品組合物之抽取方法包括:(1)苦瓜抽出物:100克新鮮苦瓜先以榨汁機榨取苦瓜汁液,餘殘的渣再以100~200 ml 90%以上的酒精浸泡6至8個小時後,過濾去除殘渣,把苦瓜汁液和酒精抽提物混合進行冷凍乾燥,製成粉末而成。(2)甘草抽出物:100克甘草經過粉碎後,加入500~1000ml體積的純水以60~100rpm振盪室溫浸泡10小時以上,除去甘草殘渣後將上清液冷凍乾燥成粉末,此一粉末再以50~100ml甲醇浸泡20小時以上,將醇溶的部份再乾燥成粉末而成。(3)破壁綠藻:100克破壁綠藻粉,以500~1000 ml 100℃沸水進行抽取60~180分鐘,將此水溶液以10mm-5 mm以分子篩過濾,除去殘渣部份,水溶液部分進行濃縮與乾燥噴粉而成。 (4)大豆蛋白粉:100克脫油的豆粕,以300~500ml的水,加入0.3%~3%蛋白分解酵素endopeptidase(E.C.3.4.24.28),於45-50度下作用6-8小時,經過過濾,取濾液,以分子篩過濾取10000 Dalton以下的成分。 A method for extracting a multi-effect compound food composition having blood fat lowering and improving fatty liver includes: (1) bitter gourd extract: 100 g fresh bitter gourd first extracts bitter gourd juice with a juicer, and the residual residue is further 100-200 After soaking for more than 90% of the alcohol for 6 to 8 hours, the residue is removed by filtration, and the bitter gourd juice and the alcohol extract are mixed and freeze-dried to obtain a powder. (2) Licorice extract: After pulverizing 100 g of licorice, add 500-1000 ml of pure water and soak for 60 hours at 60-100 rpm for 10 hours or more. After removing the licorice residue, the supernatant is freeze-dried into a powder. The mixture is further immersed in 50-100 ml of methanol for more than 20 hours, and the alcohol-soluble portion is further dried into a powder. (3) Broken green algae: 100g broken green algae powder, extracted with 500~1000 ml 100 °C boiling water for 60~180 minutes, the aqueous solution is filtered with molecular sieve at 10mm-5mm to remove the residue part, the aqueous solution part It is made by concentration and drying. (4) Soy protein powder: 100 grams of deoiled soybean meal, with 300~500ml of water, adding 0.3%~3% proteolytic enzyme endopeptidase (EC3.4.24.28), and acting at 45-50 degrees for 6-8 hours, After filtration, the filtrate was taken and filtered through a molecular sieve to obtain a component of 10,000 Dalton or less. 依申請專利範圍第4項所述之一種具有調降血脂以及改善脂肪肝的多效複方食品組合物之抽取方法,可同時活化PPAR α(降血脂)與PPAR γ(降血糖),並具有改善脂肪肝的功效。 PPAR α (hypolipidemic) and PPAR γ (hypoglycemia) can be activated simultaneously with an extraction method of a multi-effect compound food composition having blood fat lowering and improved fatty liver according to item 4 of the patent application scope. The effect of fatty liver.
TW98121165A 2009-06-24 2009-06-24 Extraction methods and compositions to ameliorate hyperlipidemia, hyperglycermia and fatty liver TWI387460B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW98121165A TWI387460B (en) 2009-06-24 2009-06-24 Extraction methods and compositions to ameliorate hyperlipidemia, hyperglycermia and fatty liver

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW98121165A TWI387460B (en) 2009-06-24 2009-06-24 Extraction methods and compositions to ameliorate hyperlipidemia, hyperglycermia and fatty liver

Publications (2)

Publication Number Publication Date
TW201100088A TW201100088A (en) 2011-01-01
TWI387460B true TWI387460B (en) 2013-03-01

Family

ID=44836453

Family Applications (1)

Application Number Title Priority Date Filing Date
TW98121165A TWI387460B (en) 2009-06-24 2009-06-24 Extraction methods and compositions to ameliorate hyperlipidemia, hyperglycermia and fatty liver

Country Status (1)

Country Link
TW (1) TWI387460B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9895400B2 (en) 2014-10-02 2018-02-20 Genmont Biotech Inc. Composition and use of Lactobacillus reuteri GMNL-263 in decreasing blood lipid levels

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102697060B (en) * 2012-05-23 2014-04-09 广东省农业科学院农业生物技术研究所 Bitter-gourd nutritious food with auxiliary hypoglycemic effect and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9895400B2 (en) 2014-10-02 2018-02-20 Genmont Biotech Inc. Composition and use of Lactobacillus reuteri GMNL-263 in decreasing blood lipid levels

Also Published As

Publication number Publication date
TW201100088A (en) 2011-01-01

Similar Documents

Publication Publication Date Title
JP6250157B2 (en) Raw coffee bean extract and method thereof
JP4229942B2 (en) Fat metabolism promoter or anti-diabetic agent
KR101756804B1 (en) Functional composition for anti-inflammation and anti-diabetic comprising the extract from a leaf of Angelica gigas Nakai and manufacturing method for functional sauce using the same
CN1870986A (en) insulin primordial stimulator
KR20160007728A (en) Method for manufacturing garlic skin extract and food composition for preventing and alleviating diabetes prepared using the same
TWI387460B (en) Extraction methods and compositions to ameliorate hyperlipidemia, hyperglycermia and fatty liver
KR100922606B1 (en) Noodles and Manufacturing Method Using Jujube Powder and Jujube Seed Extract
JP5064652B2 (en) Diabetes prevention and treatment composition and health food containing active ingredients thereof
WO1999025197A1 (en) Fenugreek compositions having reduced taste and odor and methods of use
CN110624042B (en) Composition for treating diabetic diseases
KR20130047458A (en) Composition for preventing, improving, or treating a disease controlled by ppar action
WO2007100103A1 (en) Ameliorating agent for metabolic syndrome
Ashraduzzaman et al. Vigna unguiculata linn. Walp. Seed oil exhibiting antidiabetic effects in alloxan induced diabetic rats
KR20130083427A (en) Composition for preventing, improving, or treating a disease controlled by ppar action
JP5872725B1 (en) Dipeptidyl peptidase IV inhibitory composition derived from bonito
CN101057674A (en) Composition for preventing and curing diabetes
JP2008099652A (en) Health food for metabolic syndrome
KR101478196B1 (en) Composition for the prevention of foods from oxidation and for retarding the onset of diabetes comprsing of the extract of Cudrania tricuspidata as a main component
JP5794678B2 (en) Glucagon-like peptide-1 secretion promoter
WO2010116866A1 (en) Agent for ameliorating or preventing metabolic syndrome
JP7505728B2 (en) Oral Compositions
CN1678335A (en) Agaricus Blazei Extract to Prevent Cancer Induction or Metastasis
KR102685818B1 (en) A composition for improving and treating metabolic syndrome-related diseases caused by endocrine disruptors comprising benicasa hispida extract
JP2007151537A (en) Useful material obtained from waste liquid of red bean, method for producing the same, and food and medicine containing the useful material
JP2008208081A (en) Ampk activation agent